Convalife
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $29M
Investors
- 9
About Convalife
Based in Shanghai, China, and founded in 2015, Convalife is a pharmaceutical company focusing on cancer research and development. The company has cooperation with Fosun Pharmaceutical, Jiuzhoutong Pharmaceutical Group, and other companies. The founder and CEO, Xiaokun Shen, is a doctor of the Chinese Academy of Sciences Shanghai Institute of Materia Medica and worked at Hengrui Pharmaceuticals and Novartis Pharmaceuticals. In 2022, the CVL218 project entered clinical phase II. The company is dedicated to developing drugs in the fields of tumors, viruses, and aging diseases, including PARP inhibitors CVL218 and PI3K-p110 ß/d double high selectivity inhibitor CVL237 and bispecific antibody CVL006, etc. The product pipeline covers treatment schemes for solid tumors such as breast cancer, lung cancer, bile duct cancer, and so on. The company generates revenue through developing drugs in the fields of tumors, viruses, and aging diseases, including PARP inhibitors CVL218 and PI3K-p110 ß/d double high selectivity inhibitor CVL237 and bispecific antibody CVL006, etc. The company will focus on its product commercialization layout, the global development process of multiple drug pipelines, and the company's R6D+AI new drug discovery platform.
Who invested in Convalife
9 investors across 4 rounds
See all investors in Convalife
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Convalife
Who invested in Convalife?
Convalife has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Convalife raised?
Convalife has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Convalife last raise money?
Convalife's most recent round on record is a Series C, in Mar 2025.
What does Convalife do?
Based in Shanghai, China, and founded in 2015, Convalife is a pharmaceutical company focusing on cancer research and development.
Where is Convalife headquartered?
Convalife is headquartered in Shanghai, China.
Which VCs invest in companies like Convalife?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Convalife's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Convalife? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.